Functional outcomes of children with dyskinetic cerebral palsy depend on etiology and gestational age

Yukihiro Kitai1, Satori Hirai1, Naomi Okuyama1

  • 1Department of Pediatric Neurology, Bobath Memorial Hospital, Osaka, Japan.

Insights

The causes of dyskinetic cerebral palsy (DCP) differ between term-born and preterm-born infants, impacting functional outcomes. Understanding these differences is crucial for tailored interventions in children with DCP.

Area of Science:

  • Neurology
  • Pediatrics
  • Developmental Pediatrics

Background:

  • Dyskinetic cerebral palsy (DCP) presents diverse etiologies and functional outcomes.
  • Gestational age significantly influences the presentation and underlying causes of DCP.

Purpose of the Study:

  • To investigate the distinct etiologies of DCP in term-born versus preterm-born children.
  • To analyze the relationship between etiology and functional outcomes in these two groups.

Main Methods:

  • Etiology determination using clinical course and brain MRI in 163 term-born and 136 preterm-born children.
  • Genetic analysis for unexplained cases.
  • Functional outcome assessment using GMFCS, MACS, CFCS, and EDACS.

Main Results:

  • Hypoxic ischemic encephalopathy (HIE) was the primary cause in term-born infants, while bilirubin encephalopathy (BE) predominated in preterm infants.
  • Preterm infants with BE showed poorer Gross Motor Function Classification System (GMFCS) levels compared to term infants with HIE.
  • Communication Function Classification System (CFCS) and Eating and Drinking Ability Classification System (EDACS) levels were better in preterm infants with BE than in term infants with HIE.

Conclusions:

  • Etiology of DCP varies significantly by gestational age.
  • Functional impairments in DCP are influenced by both the underlying cause and gestational age.
  • Tailored interventions considering etiology and gestational age are essential for optimizing outcomes in children with DCP.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
93
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
141
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
121
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
325
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K